Literature DB >> 15072812

Baclofen prevents MDMA-induced rise in core body temperature in rats.

Sotiria Bexis1, Benjamin D Phillis, Jennifer Ong, Jason M White, Rodney J Irvine.   

Abstract

A number of deaths have been attributed to severe hyperthermia resulting from the ingestion of 3,4-methylenedioxymethamphetamine (MDMA). The mechanisms underlying these events are unclear. In an attempt to further advance our understanding of these mechanism the present study investigated the effects of the selective GABA(A) agonist muscimol and the GABA(B) agonist baclofen on MDMA-induced responses in the rat. Baclofen at 1 and 3 mg/kg and muscimol at 0.3 and 1 mg/kg administered alone had no effect on heart rate, core body temperature or spontaneous locomotor activity as measured by radiotelemetry. MDMA at 15 mg/kg produced a significant increase in heart rate, body temperature and locomotor activity (P < 0.005) which were unaffected by prior treatment with muscimol. In contrast, prior treatment with baclofen (3 mg/kg) resulted in MDMA causing a sustained lowering of body temperature (P < 0.05), with no effect on heart rate and a small transient delay in the increase in locomotor activity. Baclofen pretreatment (3 mg/kg) not only prolonged the time taken for animals to reach a core body temperature of 40 degrees C (P < 0.001), but also reduced the percentage of rats attaining a core body temperature of 40 degrees C. These data suggest that stimulation of GABA(B) receptors may provide a mechanism for the treatment of MDMA-induced hyperthermia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15072812     DOI: 10.1016/j.drugalcdep.2003.12.004

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  7 in total

1.  Portable optical fiber probe for in vivo brain temperature measurements.

Authors:  Stefan Musolino; Erik P Schartner; Georgios Tsiminis; Abdallah Salem; Tanya M Monro; Mark R Hutchinson
Journal:  Biomed Opt Express       Date:  2016-07-20       Impact factor: 3.732

Review 2.  Clinical potential of GABAB receptor modulators.

Authors:  Jennifer Ong; David I B Kerr
Journal:  CNS Drug Rev       Date:  2005

3.  The effect of long-term repeated exposure to 3,4-methylenedioxymethamphetamine on cardiovascular and thermoregulatory changes.

Authors:  Emily Joy Jaehne; Abdallah Salem; Rodney James Irvine
Journal:  Psychopharmacology (Berl)       Date:  2008-08-06       Impact factor: 4.530

4.  Quantitative pharmacokinetic-pharmacodynamic modelling of baclofen-mediated cardiovascular effects using BP and heart rate in rats.

Authors:  Harriet Kamendi; Herbert Barthlow; David Lengel; Marie-Eve Beaudoin; Debra Snow; Jerome T Mettetal; Russell A Bialecki
Journal:  Br J Pharmacol       Date:  2016-08-25       Impact factor: 8.739

5.  Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia.

Authors:  Emily Joy Jaehne; Abdallah Salem; Rodney James Irvine
Journal:  Psychopharmacology (Berl)       Date:  2007-05-27       Impact factor: 4.530

6.  Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects.

Authors:  Sami Ben Hamida; Erin Plute; Brigitte Cosquer; Christian Kelche; Byron C Jones; Jean-Christophe Cassel
Journal:  Psychopharmacology (Berl)       Date:  2007-11-27       Impact factor: 4.415

7.  Ethanol-MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination.

Authors:  Sami Ben Hamida; Erin Plute; Sonia Bach; Christine Lazarus; Antoine Tracqui; Christian Kelche; Anne Pereira de Vasconcelos; Byron C Jones; Jean-Christophe Cassel
Journal:  Psychopharmacology (Berl)       Date:  2007-03-08       Impact factor: 4.415

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.